[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 168, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 51, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 715350, "exercisedValue": 0, "unexercisedValue": 341880}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 598862, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 22.33, "open": 22.01, "dayLow": 21.3321, "dayHigh": 22.16, "regularMarketPreviousClose": 22.33, "regularMarketOpen": 22.01, "regularMarketDayLow": 21.3321, "regularMarketDayHigh": 22.16, "payoutRatio": 0.0, "beta": 2.182, "forwardPE": -8.474443, "volume": 1011329, "regularMarketVolume": 1011329, "averageVolume": 1880256, "averageVolume10days": 4806020, "averageDailyVolume10Day": 4806020, "bid": 15.54, "ask": 26.07, "bidSize": 2, "askSize": 2, "marketCap": 2395378944, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 25.3, "allTimeHigh": 63.78, "allTimeLow": 2.09, "priceToSalesTrailing12Months": 247.48207, "fiftyDayAverage": 18.0656, "twoHundredDayAverage": 11.475675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1722404096, "profitMargins": 0.0, "floatShares": 75310645, "sharesOutstanding": 110335277, "sharesShort": 15876802, "sharesShortPriorMonth": 14324512, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1731, "heldPercentInsiders": 0.07855, "heldPercentInstitutions": 0.82276, "shortRatio": 9.3, "shortPercentOfFloat": 0.18040001, "impliedSharesOutstanding": 110335277, "bookValue": 2.878, "priceToBook": 7.5434327, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -222743008, "trailingEps": -2.96, "forwardEps": -2.56182, "enterpriseToRevenue": 177.953, "enterpriseToEbitda": -8.42, "52WeekChange": 1.172179, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 21.71, "targetHighPrice": 40.0, "targetLowPrice": 26.0, "targetMeanPrice": 34.25, "targetMedianPrice": 33.0, "recommendationMean": 1.15385, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 272639008, "totalCashPerShare": 2.973, "ebitda": -204563008, "totalDebt": 4013000, "quickRatio": 8.67, "currentRatio": 8.902, "totalRevenue": 9679000, "debtToEquity": 1.521, "revenuePerShare": 0.122, "returnOnAssets": -0.46480998, "returnOnEquity": -0.93037003, "grossProfits": -164727008, "freeCashflow": -127748248, "operatingCashflow": -185026000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -21.37101, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "corporateActions": [], "postMarketTime": 1766793792, "regularMarketTime": 1766782801, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.460619, "postMarketPrice": 21.81, "postMarketChange": 0.10000038, "regularMarketChange": -0.620001, "regularMarketDayRange": "21.3321 - 22.16", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1880256, "fiftyTwoWeekLowChange": 16.56, "fiftyTwoWeekLowChangePercent": 3.2155337, "fiftyTwoWeekRange": "5.15 - 25.3", "fiftyTwoWeekHighChange": -3.5900002, "fiftyTwoWeekHighChangePercent": -0.14189725, "marketState": "CLOSED", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "regularMarketChangePercent": -2.77654, "regularMarketPrice": 21.71, "fiftyTwoWeekChangePercent": 117.217896, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.96, "epsForward": -2.56182, "epsCurrentYear": -2.19909, "priceEpsCurrentYear": -9.872265, "fiftyDayAverageChange": 3.6443996, "fiftyDayAverageChangePercent": 0.20173146, "twoHundredDayAverageChange": 10.234324, "twoHundredDayAverageChangePercent": 0.8918277, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]